Importantly, this axis protects mice against the development of overt inflammation in models of sepsis, viral infection, and psoriasis, demonstrating a generalized mechanism, and suggesting that promoting the activin A/Smad3 pathway could provide a therapeutic strategy in these diseases. The gene discussed is SMAD3; the disease is Sepsis.